About Bevacizumab (ABEVMY)
            
            Class: | Monoclonal antibody (VEGF inhibitor)  
Use: | Treatment of various cancers including metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer, among others.  
Adult dose: | Typically, 5 mg/kg administered intravenously every 2 weeks or 10 mg/kg every 3 weeks, depending on the specific cancer type and treatment regimen.  
Pediatric dose: | Safety and efficacy not established in pediatric patients; use is generally not recommended. 
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (VEGF inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of various cancers including metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer, among others.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 2°C to 8°C (36°F to 46°F); do not freeze. Protect from light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Mylan IRE Healthcare Limited, Ireland
                    
                    
                    Package Size
                    1 Glass Vial (4 ml)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 1585.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Typically, 5 mg/kg administered intravenously every 2 weeks or 10 mg/kg every 3 weeks, depending on the specific cancer type and treatment regimen.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; use is generally not recommended.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include hypertension, fatigue, headache, gastrointestinal perforations, proteinuria, and increased risk of bleeding.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to bevacizumab or any component of the formulation; patients with recent surgery, wound healing complications, or significant bleeding disorders.
         
        
        
            
                Important Warnings
            
            Risk of serious adverse reactions including gastrointestinal perforations, hemorrhage, and arterial thromboembolic events; monitor blood pressure regularly; avoid use in patients with recent surgery or those with significant bleeding risks.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.